Interestingly, three gastrointestinal cancer types including pancreatic, gastric, and colorectal cancer, and bladder cancer were then identified as the most promising cancer types for cross-cancer prediction from EGFR-mutant NSCLC by our CONCORD analysis (Figure 5A). The gene discussed is EGFR; the disease is urinary bladder carcinoma.